RecruitingNCT03981497

Microwave Ablation for Treatment of Small Renal Tumors and Primary and Secondary Liver Neoplasms

Retrospective and Perspective Analysis of Short, Medium and Long Term Clinical Performance of Patients Undergoing MicrowaveThermal Ablation for Treatment of Small Renal Tumors and Primary and Secondary Liver Neoplasms

Sponsor

Francesco De Cobelli

Enrollment

500 participants

Start Date

Feb 28, 2018

Study Type

OBSERVATIONAL

Conditions

Liver Cancer Renal Cell Carcinoma Kidney Cancer Liver Metastasis Colon Cancer

Summary

The goal of this observational study is to collect data on efficacy and safety of microwave ablation (MWA) used to treat subjects with primary and secondary liver malignancies and renal malignancies. The main question it aims to evaluate the short, medium and long-term clinical course of patients treated with MWA. Participants will not alter their normal clinical and therapeutic practice, due to the observational nature of the study, and all data regarding microwave treatments will be collected (including demographic data). follow their normal clinical and therapeutic path

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study uses microwave energy to destroy small tumors in the liver or kidney without surgery — a procedure called microwave ablation. It is designed for patients who are not good candidates for conventional surgery. **You may be eligible if...** - You are over 18 - You have primary liver cancer (up to 3 nodules, each 3 cm or less) or secondary liver tumors (spread from another cancer, up to 3 cm) that can be completely cleared - You have a small kidney tumor (under 4 cm), including multiple tumors if you have von Hippel-Lindau syndrome - You are not a suitable candidate for surgery **You may NOT be eligible if...** - You are pregnant - You have unmanageable blood clotting problems - Your cancer has spread extensively outside the liver or kidney - You have had a surgical connection between your bile duct and intestine (for liver ablation) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.